BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022

  Acasti Pharma Inc. provided a business update and announced its operating and financial results for the first quarter of fiscal 2022 ended June 30, 2021.

  August 12, 2021

   · 

  14 min read
• Business

  Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update

  Novan, Inc., announced its financial and operating results for the quarter ended June 30, 2021 and provided a corporate update.

  August 12, 2021

   · 

  16 min read
• Business

  Zentalis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update

  Zentalis Pharmaceuticals, Inc.today announced financial results for the second quarter ended June 30, 2021 and highlighted recent corporate accomplishments.

  August 12, 2021

   · 

  10 min read
• Business

  Ocuphire Announces Financial Results for the Second Quarter 2021 and Provides Corporate Update

  Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, announced financial results for the second quarter of 2021 and provided a corporate update.

  August 12, 2021

   · 

  13 min read
• Business

  VYNE Therapeutics Announces Licensing of BET Inhibitor Platform for Immuno-Inflammatory Conditions with In4Derm Limited

  VYNE Therapeutics Inc. today announced that it has entered into an exclusive license agreement (the “License Agreement”) with In4Derm Limited

  August 12, 2021

   · 

  10 min read
• FDA

  Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%)

  Cipla Limited today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA).

  August 12, 2021

   · 

  2 min read
• Business

  HOOKIPA Pharma Reports Second Quarter 2021 Financial Results and Recent Highlights

  HOOKIPA Pharma Inc. today reported financial results and business highlights for the second quarter of 2021.

  August 12, 2021

   · 

  9 min read
• Business

  Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

  Antheia and Ginkgo Bioworks today announced a partnership to accelerate the development and production of essential medicines.

  August 12, 2021

   · 

  10 min read
• Carotid Artery Stenosis Market: High prevalence of carotid artery stenosis among the geriatric population to drive the market

  Carotid stenosis, also known as carotid artery disease, is characterized by the narrowing of the carotid arteries, the primary blood vessels that carry oxygenated blood to the brain.

  August 12, 2021

   · 

  4 min read
• Home Respiratory Therapy Emerges as Top-selling Homecare Setting Solution in 2020

  Fact.MR – A Market Research and Competitive Intelligence Provider: In its upcoming report, Fact.MR projects steady demand for global home respiratory therapy.

  August 12, 2021

   · 

  8 min read